Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics.
Saved in:
| Title: | Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics. |
|---|---|
| Authors: | Wacheck V; Department of Clinical Pharmacology, Medical University of Vienna, Währinger Gürtel, Vienna, Austria;, Lahn M, Dickinson G, Füreder W, Meyer R, Herndlhofer S, Füreder T, Dorfner G, Pillay S, André V, Burkholder TP, Akunda JK, Flye-Blakemore L, Van Bockstaele D, Schlenk RF, Sperr WR, Valent P |
| Source: | Cancer management and research [Cancer Manag Res] 2011; Vol. 3, pp. 157-75. Date of Electronic Publication: 2011 May 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101512700 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1322 (Electronic) Linking ISSN: 11791322 NLM ISO Abbreviation: Cancer Manag Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
